Regulatory controversies surround blood glucose monitoring devices

Journal of Diabetes Science and Technology

Volumn 4, Issue 2, 2010, Pages 231-235

  Klonoff, David C ^a  

^a Mills Peninsula Health Services   (United States)

Author keywords

FDA; Glucose; Monitoring devices; Regulatory controversy

Indexed keywords

INSULIN;

BLOOD GLUCOSE MONITORING; CHEMICALLY INDUCED DISORDER; EDITORIAL; FOOD AND DRUG ADMINISTRATION; GLUCOSE BLOOD LEVEL; HOSPITAL; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; INSTRUMENTATION; LONG TERM CARE; MEDICAL ERROR; REPRODUCIBILITY; SELF CARE; STANDARD; UNITED STATES;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; HOSPITALS; HUMANS; HYPOGLYCEMIA; INPATIENTS; INSULIN; LONG-TERM CARE; MEDICAL ERRORS; REPRODUCIBILITY OF RESULTS; SELF CARE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77955480844     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681000400201     Document Type: Editorial

References (20)

1. Pinkos AF. FDA Meeting: Clinical Accuracy Requirements for Point of Care Blood Glucose Meters. J Diabetes Sci Technol 2010;(4)2:496.
2. http://www.nytimes.com/packages/pdf/health/20090717-MONITOR-1.pdf [cited 2010 Jan 20].
3. http://www.iso.org/iso/iso-catalogue/catalogue-tc/catalogue-detail.htm? csnumber=26309 [cited 2010 Jan 20].
4. Fahy BG, Coursin DB. An analysis: hyperglycemic intensive care patients need continuous glucose monitoring - easier said than done. J Diabetes Sci Technol. 2008;2(2):201-4.
5. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300(8):933-44.
6. Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821-7.
7. Scott MG, Bruns DE, Sacks DB. Tight glucose control in critically ill adults. JAMA. 2008;300(23):2725-6.
8. Bellomo R, Egi M. What is a NICE-SUGAR for patients in the intensive care unit? Mayo Clin Proc. 2009;84(5):400-2.
9. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-97.
10. Sacks DB. Intensive glucose control in the ICU: is SUGAR NICE? Nature Rev Endocrinol. 2009;5(9):473-4.
11. Van den Berghe G, Schetz M, Vlasselaers D, Hermans G, Wilmer A, Bouillon R, Mesotten D. Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab. 2009;94(9):3163-70.
12. Kanji S, Buffie J, Hutton B, Bunting PS, Singh A, McDonald K, Fergusson D, McIntyre LA, Hebert PC. Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005;33(12):2778-85. (Pubitemid 41816412)
13. College of American Pathologists. CAP survey: participant summary for whole blood glucose survey 2008 set WBG-B. Northfield, IL: College of American Pathologists; 2008.
14. Boyd JC, Bruns DE. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin Chem. 2001;47(2):209-14. (Pubitemid 32142918)
15. Boyd JC, Bruns DE. Monte Carlo simulation in establishing analytical quality requirements for clinical laboratory tests meeting clinical needs. Methods Enzymol. 2009;467:411-33.
16. Karon BS, Deobald G, Klee GG. Effect of different glucose meter error tolerances on dosing errors during intravenous insulin administration. Point Care. 2008;7:124.
17. Boren SA, Clarke, WL. Analytical and clinical performance of blood glucose monitors. J Diabetes Sci Technol. 2010;4(1):84-97.
18. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ PublicHealthNotifications/ucm176992.htm [cited 2010 Jan 20].
19. Schleis TG. Interference of maltose, icodextrin, galactose, or xylose with some blood glucose monitoring systems. Pharmacotherapy. 2007;27(9):1313-21. (Pubitemid 47339129)
20. Krouwer JS, Cembrowski G. A review of standards and statistics used to describe blood glucose monitor performance. J Diabetes Science Technol. 2010;4(1):75-83.